The National Institutes of Health (NIH) intends to award a non-competitive contract to LabLogic Systems, Inc. for a high-sensitivity preclinical microSPECT imaging system to support the Molecular Imaging Branch’s cancer research. The system must enable quantitative tomographic imaging, rapid whole-body workflows, and compatibility with standard DICOM formats for dosimetry analysis. Performance of services will be at the NIH facility in Bethesda, Maryland. The acquisition is conducted under simplified acquisition procedures, with a budget not exceeding the simplified acquisition threshold of $350,000. Responses from interested parties are due by July 24, 2026, at 9:00 AM Eastern time.